Terms: = Gastric cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
66 results:
1. Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-akt2 signaling pathway.
Li C; Wang S; Ma X; Wang T; Lu R; Jia X; Leng Z; Kong X; Zhang J; Li L
Int Immunopharmacol; 2023 Mar; 116():109729. PubMed ID: 37800555
[TBL] [Abstract] [Full Text] [Related]
2. LAG3 in gastric cancer: it's complicated.
Ulase D; Behrens HM; Krüger S; Heckl SM; Ebert U; Becker T; Röcken C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10797-10811. PubMed ID: 37311986
[TBL] [Abstract] [Full Text] [Related]
3. Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia gastric Adenocarcinoma in a Large Diverse Population in the United States.
Li D; Jiang SF; Lei NY; Shah SC; Corley DA
Gastroenterology; 2023 Aug; 165(2):391-401.e2. PubMed ID: 37142201
[TBL] [Abstract] [Full Text] [Related]
4. Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis.
Haruma K; Kinoshita Y; Yao T; Kushima R; Akiyama J; Aoyama N; Kanoo T; Miyata K; Kusumoto N; Uemura N
BMC Gastroenterol; 2023 May; 23(1):139. PubMed ID: 37127558
[TBL] [Abstract] [Full Text] [Related]
5. Development of the new pH-driven carrier from alginate/carboxymethyl starch bio-coated co-drugs@COF-OH for controlled and concomitant colon cancer treatment.
Pooresmaeil M; Namazi H
Int J Biol Macromol; 2023 Jun; 239():124322. PubMed ID: 37019202
[TBL] [Abstract] [Full Text] [Related]
6. Patient-Reported Outcomes of Individuals with gastric cancer Undergoing Totally Laparoscopic Versus Laparoscopic-Assisted Total Gastrectomy: A Real-World, Propensity Score-Matching Analysis.
Lin GT; Chen JY; Chen QY; Que SJ; Liu ZY; Zhong Q; Wang JB; Lin JX; Lu J; Lin M; Huang ZN; Xie JW; Li P; Huang CM; Zheng CH
Ann Surg Oncol; 2023 Mar; 30(3):1759-1769. PubMed ID: 36414907
[TBL] [Abstract] [Full Text] [Related]
7. Oesophageal and gastric cancer After Bariatric Surgery: an Up-to-Date Systematic Scoping Review of Literature of 324 Cases.
Parmar C; Pouwels S
Obes Surg; 2022 Dec; 32(12):3854-3862. PubMed ID: 36241765
[TBL] [Abstract] [Full Text] [Related]
8. First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis.
Liu T; Bai Y; Lin X; Li W; Wang J; Zhang X; Pan H; Bai C; Bai L; Cheng Y; Zhang J; Zhong H; Ba Y; Hu W; Xu R; Guo W; Qin S; Yang N; Lu J; Shitara K; Lei M; Li M; Bao N; Chen T; Shen L
Int J Cancer; 2023 Feb; 152(4):749-760. PubMed ID: 36121651
[TBL] [Abstract] [Full Text] [Related]
9. Insulin for hyperglycemia prevention and management during postgastrectomy nutrition support in gastric cancer: Reduced complications in a retrospective cohort study in China.
Lan N; Zhang L; Zhou Y; Lu Y; Jiao F; Zhao Y; Wang J; Hao J; Deng C; Ren Y; Guan Q; Yuan W
Asia Pac J Clin Nutr; 2022 Mar; 31(1):49-56. PubMed ID: 35357103
[TBL] [Abstract] [Full Text] [Related]
10. Cost-effectiveness modelling of use of urea breath test for the management of
Pritchard DM; Bornschein J; Beales I; Beresniak A; Salhi H; Malfertheiner P
BMJ Open Gastroenterol; 2021 Jul; 8(1):. PubMed ID: 34244244
[TBL] [Abstract] [Full Text] [Related]
11. Prevalence and endoscopic treatment outcomes of upper gastrointestinal neoplasms in familial adenomatous polyposis.
Noh JH; Song EM; Ahn JY; Yang DH; Lee W; Hong J; Kim A; Na HK; Lee JH; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
Surg Endosc; 2022 Feb; 36(2):1310-1319. PubMed ID: 33709227
[TBL] [Abstract] [Full Text] [Related]
12. Management and outcomes of resectable gastric conduit cancer: a retrospective comparative study of 51 cases.
Urabe M; Haruta S; Tanaka M; Yago A; Ohkura Y; Tanaka T; Hoteya S; Ueno M; Udagawa H
Langenbecks Arch Surg; 2021 Aug; 406(5):1433-1441. PubMed ID: 33409582
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant treatment for Patients with Resectable HER2-Positive gastric cancer.
He Q; Chen J; Zhou K; Jin C; Wang A; Ji K; Ji X; Zhang J; Wu X; Li X; Bu Z; Ji J
Ann Surg Oncol; 2021 Aug; 28(8):4413-4422. PubMed ID: 33393029
[TBL] [Abstract] [Full Text] [Related]
14. Polyglycolic acid sheets decrease post-endoscopic submucosal dissection bleeding in early gastric cancer: A systematic review and meta-analysis.
Li F; Xiong F; Xu ZL; Zhang DG; Yao J; Wang LS
J Dig Dis; 2020 Aug; 21(8):437-444. PubMed ID: 32573104
[TBL] [Abstract] [Full Text] [Related]
15. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
[TBL] [Abstract] [Full Text] [Related]
16. Clinical utility of treatment method conversion during single-session endoscopic ultrasound-guided biliary drainage.
Minaga K; Takenaka M; Yamao K; Kamata K; Omoto S; Nakai A; Yamazaki T; Okamoto A; Ishikawa R; Yoshikawa T; Chiba Y; Watanabe T; Kudo M
World J Gastroenterol; 2020 Mar; 26(9):947-959. PubMed ID: 32206005
[TBL] [Abstract] [Full Text] [Related]
17. Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom.
Brown J; Liepa AM; Bapat B; Madhwani S; Lorenzen S; García-Foncillas J; Candrilli SD; Kaye JA
Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13213. PubMed ID: 31883156
[TBL] [Abstract] [Full Text] [Related]
18. [Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors].
Zhai XJ; Yu SL; Ma YH; Wang F; Yang MJ; Lian YJ; Yu XX; Fan QX; Song LJ
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2527-2531. PubMed ID: 31484281
[No Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of paclitaxel liposomes as first-line chemotherapy in advanced gastric cancer.
Han G; Shi J; Mi L; Li N; Shi H; Li C; Shan B; Yin F
Future Oncol; 2019 May; 15(14):1617-1627. PubMed ID: 31038363
[No Abstract] [Full Text] [Related]
20. Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway.
Li J; Feng D; Gao C; Zhang Y; Xu J; Wu M; Zhan X
Int J Oncol; 2019 May; 54(5):1591-1600. PubMed ID: 30816492
[TBL] [Abstract] [Full Text] [Related]
[Next]
